|
| 2H-Indol-2-one, 5,6-dichloro-3-[1,3-dihydro-3-(methoxyimino)-2H-indol-2-ylidene]-1,3-dihydro- Basic information |
Product Name: | 2H-Indol-2-one, 5,6-dichloro-3-[1,3-dihydro-3-(methoxyimino)-2H-indol-2-ylidene]-1,3-dihydro- | Synonyms: | 2H-Indol-2-one, 5,6-dichloro-3-[1,3-dihydro-3-(methoxyimino)-2H-indol-2-ylidene]-1,3-dihydro-;Ky19382;A3051;2H-Indol-2-one, 5,6-dichloro-3-[1,3-dihydro-3-(methoxyimino)-2H-indol-2-ylidene]-1,3-dihydro-Ky19382;Glycogen synthase kinase 3,Beta catenin,β-catenin,GSK-3,KY 19382,inhibit,Wnt,Inhibitor,KY-19382,A 3051,KY19382,A-3051,Glycogen synthase kinase-3;5',6'-Dichloro-3-(methoxyimino)-[2,3'-biindolinylidene]-2'-one;KY19382(A3051);5',6'-Dichloro-3-(methoxyimino)-[2,3'-biindolinylidene]-2'-one | CAS: | 2226664-93-1 | MF: | C17H11Cl2N3O2 | MW: | 360.19 | EINECS: | | Product Categories: | | Mol File: | 2226664-93-1.mol | |
| 2H-Indol-2-one, 5,6-dichloro-3-[1,3-dihydro-3-(methoxyimino)-2H-indol-2-ylidene]-1,3-dihydro- Chemical Properties |
density | 1.58±0.1 g/cm3(Predicted) | pka | 8.80±0.20(Predicted) |
| 2H-Indol-2-one, 5,6-dichloro-3-[1,3-dihydro-3-(methoxyimino)-2H-indol-2-ylidene]-1,3-dihydro- Usage And Synthesis |
Uses | KY 19382 is a potent and orally active dual inhibitor of CXXC5-DVL and GSK3β. |
| 2H-Indol-2-one, 5,6-dichloro-3-[1,3-dihydro-3-(methoxyimino)-2H-indol-2-ylidene]-1,3-dihydro- Preparation Products And Raw materials |
|